Meike de Wit Selected Research

Colonic Neoplasms (Colon Cancer)

1/2021	Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.
9/2015	MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.
12/2013	Lumican and versican are associated with good outcome in stage II and III colon cancer.
4/2013	Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meike de Wit Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 04/2010
15	Adenoma (Adenomas) 01/2021 - 04/2010
11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2010
9	Carcinoma (Carcinomatosis) 01/2017 - 04/2010
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 04/2013
2	Carcinogenesis 01/2021 - 05/2010
2	Microsatellite Instability 09/2015 - 05/2014
2	Chromosomal Instability (Chromosome Stability) 05/2014 - 04/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Polyps 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Adenocarcinoma 04/2010

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2010
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2010
6	Calcibiotic Root Canal SealerIBA 01/2020 - 04/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2012
6	Messenger RNA (mRNA)IBA 01/2017 - 04/2010
3	ProteomeIBA 03/2014 - 05/2010
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2011
2	ParaffinIBA 01/2021 - 04/2013
2	Formaldehyde (Formol)FDA Link 01/2021 - 04/2013
2	LumicanIBA 01/2017 - 12/2013
2	Versicans (Versican)IBA 01/2017 - 12/2013
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 12/2013
2	Carrier Proteins (Binding Protein)IBA 05/2014 - 07/2011
2	ChromatinIBA 05/2014 - 05/2010
2	Aurora Kinase AIBA 11/2012 - 04/2010
1	nidogen (entactin)IBA 01/2021
1	N 30IBA 01/2021
1	fibulin 2IBA 01/2021
1	CDX2 Transcription FactorIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	SerpinsIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	HaptoglobinsIBA 01/2020
1	Complement System Proteins (Complement)IBA 12/2017
1	LigandsIBA 09/2015
1	CarbohydratesIBA 09/2015
1	Tn antigenIBA 09/2015
1	AntibodiesIBA 05/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2014
1	Conditioned Culture MediaIBA 11/2013
1	Cellular Apoptosis Susceptibility ProteinIBA 08/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2012
1	Glucose Transporter Type 1IBA 06/2012
1	Prion ProteinsIBA 06/2012
1	Chitinase-3-Like Protein 1IBA 05/2012
1	Keratin-20 (Cytokeratin 20)IBA 07/2011
1	Peptides (Polypeptides)IBA 05/2010
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 04/2010
1	Biological ProductsIBA 04/2010
1	Tumor Biomarkers (Tumor Markers)IBA 04/2010

Therapy/Procedure

2	Adjuvant Chemotherapy 09/2015 - 12/2013
1	Ligation 01/2018
1	Therapeutics 03/2014